These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31459022)

  • 1. Biotransformation, Using Recombinant CYP450-Expressing Baker's Yeast Cells, Identifies a Novel CYP2D6.10
    Williams IS; Gatchie L; Bharate SB; Chaudhuri B
    ACS Omega; 2018 Aug; 3(8):8903-8912. PubMed ID: 31459022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine.
    Kirkwood LC; Nation RL; Somogyi AA
    Br J Clin Pharmacol; 1997 Dec; 44(6):549-55. PubMed ID: 9431830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
    Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
    Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic determinants of codeine induction by rifampin: the impact on codeine's respiratory, psychomotor and miotic effects.
    Caraco Y; Sheller J; Wood AJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):330-6. PubMed ID: 9103514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects.
    Caraco Y; Sheller J; Wood AJ
    J Pharmacol Exp Ther; 1999 Jul; 290(1):413-22. PubMed ID: 10381807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the in vitro CYP450 mediated metabolism of the polymorphic CYP2D6 probe drug codeine in horses.
    Knych HK; Baden RW; Gretler SR; McKemie DS
    Biochem Pharmacol; 2019 Oct; 168():184-192. PubMed ID: 31295464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacogenetics of codeine hypoalgesia.
    Sindrup SH; Brøsen K
    Pharmacogenetics; 1995 Dec; 5(6):335-46. PubMed ID: 8845855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous codeine and morphine in poor and extensive metabolisers of the CYP2D6 (debrisoquine/sparteine) polymorphism.
    Mikus G; Bochner F; Eichelbaum M; Horak P; Somogyi AA; Spector S
    J Pharmacol Exp Ther; 1994 Feb; 268(2):546-51. PubMed ID: 8113966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity.
    Caraco Y; Tateishi T; Guengerich FP; Wood AJ
    Drug Metab Dispos; 1996 Jul; 24(7):761-4. PubMed ID: 8818573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification, and characterization of mouse CYP2d22.
    Yu AM; Haining RL
    Drug Metab Dispos; 2006 Jul; 34(7):1167-74. PubMed ID: 16595712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects.
    Gelston EA; Coller JK; Lopatko OV; James HM; Schmidt H; White JM; Somogyi AA
    Br J Clin Pharmacol; 2012 May; 73(5):786-94. PubMed ID: 22092298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of codeine on gastrointestinal motility in relation to CYP2D6 phenotype.
    Mikus G; Trausch B; Rodewald C; Hofmann U; Richter K; Gramatté T; Eichelbaum M
    Clin Pharmacol Ther; 1997 Apr; 61(4):459-66. PubMed ID: 9129563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic determination of the effects of codeine and prediction of drug interactions.
    Caraco Y; Sheller J; Wood AJ
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1165-74. PubMed ID: 8819499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6 phenotype-specific codeine population pharmacokinetics.
    Linares OA; Fudin J; Schiesser WE; Daly Linares AL; Boston RC
    J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):4-15. PubMed ID: 25562725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolites.
    Lötsch J; Skarke C; Schmidt H; Rohrbacher M; Hofmann U; Schwab M; Geisslinger G
    Clin Pharmacol Ther; 2006 Jan; 79(1):35-48. PubMed ID: 16413240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine.
    Pai HV; Kommaddi RP; Chinta SJ; Mori T; Boyd MR; Ravindranath V
    J Biol Chem; 2004 Jun; 279(26):27383-9. PubMed ID: 15051713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI).
    Dayer P; Desmeules J; Leemann T; Striberni R
    Biochem Biophys Res Commun; 1988 Apr; 152(1):411-6. PubMed ID: 3358767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of inhibitors on the O- and N-demethylation of codeine in human liver microsomes.
    Yue QY; Säwe J
    Eur J Clin Pharmacol; 1997; 52(1):41-7. PubMed ID: 9143866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects.
    Poulsen L; Brøsen K; Arendt-Nielsen L; Gram LF; Elbaek K; Sindrup SH
    Eur J Clin Pharmacol; 1996; 51(3-4):289-95. PubMed ID: 9010701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
    VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G
    Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.